{"id":"NCT00696241","sponsor":"Takeda","briefTitle":"Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension","officialTitle":"A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-491 in Subjects With Essential Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-06","primaryCompletion":"2008-10","completion":"2008-10","firstPosted":"2008-06-12","resultsPosted":"2011-04-19","lastUpdate":"2011-07-29"},"enrollment":1275,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"Azilsartan medoxomil and olmesartan","otherNames":["TAK-491","Edarbi"]},{"type":"DRUG","name":"Azilsartan medoxomil and olmesartan","otherNames":["TAK-491","Edarbi"]},{"type":"DRUG","name":"Azilsartan medoxomil and olmesartan","otherNames":["TAK-491","Edarbi"]},{"type":"DRUG","name":"Olmesartan","otherNames":["BenicarÂ®"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Azilsartan Medoxomil 20 mg QD","type":"EXPERIMENTAL"},{"label":"Azilsartan Medoxomil 40 mg QD","type":"EXPERIMENTAL"},{"label":"Azilsartan Medoxomil 80 mg QD","type":"EXPERIMENTAL"},{"label":"Olmesartan 40 mg QD","type":"ACTIVE_COMPARATOR"},{"label":"Placebo QD","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine the safety and efficacy of azilsartan medoxomil, once daily (QD), compared to placebo and olmesartan in participants with essential hypertension.","primaryOutcome":{"measure":"Change From Baseline in the 24-hour Mean Systolic Blood Pressure Measured by Ambulatory Blood Pressure Monitoring.","timeFrame":"Baseline and Week 6.","effectByArm":[{"arm":"Azilsartan Medoxomil 20 mg QD","deltaMin":-12.15,"sd":0.709},{"arm":"Azilsartan Medoxomil 40 mg QD","deltaMin":-13.48,"sd":0.704},{"arm":"Azilsartan Medoxomil 80 mg QD","deltaMin":-14.62,"sd":0.706},{"arm":"Olmesartan 40 mg QD","deltaMin":-12.56,"sd":0.696},{"arm":"Placebo QD","deltaMin":-1.4,"sd":1.004}],"pValues":[{"comp":"OG000 vs OG004","p":"<0.001"},{"comp":"OG001 vs OG004","p":"<0.001"},{"comp":"OG002 vs OG004","p":"<0.001"},{"comp":"OG000 vs OG003","p":"0.687"},{"comp":"OG001 vs OG003","p":"0.352"},{"comp":"OG002 vs OG003","p":"0.038"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":85,"countries":["United States","Argentina","Mexico"]},"refs":{"pmids":["21282560","21272195"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":283},"commonTop":["Headache","Dyslipidemia"]}}